Why the study?
Does prazosin compared to phenoxybenzamine alter hemodynamic and neuroendocrine responses in patients with essential hypertension?
Does prazosin compared to phenoxybenzamine alter hemodynamic and neuroendocrine responses in patients with essential hypertension?
Acute administration of prazosin and phenoxybenzamine produces different hemodynamic and neuroendocrine responses in essential hypertension, but chronic therapy results in similar profiles, suggesting prejunctional alpha 2-receptors have no functional significance in these patients.
Answers are grounded in this paper and cite their sources.
Acute differences in alpha-blockade hemodynamics equalize chronically; challenges functional role of prejunctional alpha2-receptors in essential hypertension.
We investigated the relevance of the selective alpha 1-adrenergic receptor blockade produced by prazosin to its blood pressure-lowering efficacy in man. The hemodynamic and neuroendocrine responses to the acute and chronic oral administration of prazosin and phenoxybenzamine were compared in a randomized, double-blind, placebo-controlled, crossover study of 11 patients with essential hypertension. These responses were also evaluated during lower body negative pressure and dynamic bicycle exercise, which produce potent but diversified activation of the sympathetic nervous system. In the acute studies, arterial blood pressure decreased to similar levels with prazosin or phenoxybenzamine; however, hemodynamic and neuroendocrine responses differed both before and during sympathetic nervous system activation. Prazosin lowered arterial blood pressure by reducing total peripheral resistance (p less than 0.05). In contrast, phenoxybenzamine produced a modest reduction in cardiac output (8%, p less than 0.05) with little change in total peripheral resistance, forearm vascular resistance or forearm blood flow. Additionally, plasma norepinephrine concentration and heart rate rose to significantly higher levels with prazosin (p less than 0.02) than with phenoxybenzamine, a difference that was most evident with lower body negative pressure or dynamic exercise. Baroreceptor control of arterial pressure homeostasis was preserved with both agents, except during marked degrees of cardiovascular stress. With chronic therapy, the circulatory responses adapted to the alpha-adrenergic antagonists, and both drugs produced similar hemodynamic and neuroendocrine profiles. The differences with acute administration may be the result of a more rapid onset of action and a more marked degree of alpha-adrenergic blockage with prazosin than with phenoxybenzamine therapy, rather than to any difference in their alpha 1- and alpha 2-adrenergic receptor blocking properties. Moreover, the findings of the present study suggest that the prejunctional alpha 2-receptor, autoinhibitory to sympathetic neuronal norepinephrine release, is of no functional significance in patients with essential hypertension.
No takes yet. Share an insight, caveat, or question.
Mulvihill-Wilson et al. (1983) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: